Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetirizine Hydrochloride Injection for Acute Urticaria (Phase III, Randomized Double-Blind Active-Controlled)
CTR20233269Phase 3Completed
- Sponsor
- Shandong New Era Pharmaceutical
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cetirizine in acute urticaria, sponsored by Shandong New Era Pharmaceutical. Started Nov 2023; status: completed.
02
Drugs
cetirizine
03
Conditions
acute urticaria
Beyond the preview
Go deeper on CTR20233269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233269.